These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Phenotypic gender differences in subjects with familial partial lipodystrophy (Dunnigan variety) due to a nuclear lamin A/C R482W mutation. Araújo-Vilar D; Loidi L; Domínguez F; Cabezas-Cerrato J Horm Metab Res; 2003 Jan; 35(1):29-35. PubMed ID: 12669268 [TBL] [Abstract][Full Text] [Related]
9. Inherited lipodystrophies and the metabolic syndrome. Monajemi H; Stroes E; Hegele RA; Fliers E Clin Endocrinol (Oxf); 2007 Oct; 67(4):479-84. PubMed ID: 17561981 [TBL] [Abstract][Full Text] [Related]
10. Phenotypic heterogeneity in patients with familial partial lipodystrophy (dunnigan variety) related to the site of missense mutations in lamin a/c gene. Garg A; Vinaitheerthan M; Weatherall PT; Bowcock AM J Clin Endocrinol Metab; 2001 Jan; 86(1):59-65. PubMed ID: 11231979 [TBL] [Abstract][Full Text] [Related]
11. Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C. Speckman RA; Garg A; Du F; Bennett L; Veile R; Arioglu E; Taylor SI; Lovett M; Bowcock AM Am J Hum Genet; 2000 Apr; 66(4):1192-8. PubMed ID: 10739751 [TBL] [Abstract][Full Text] [Related]
13. Overlapping syndrome with familial partial lipodystrophy, Dunnigan variety and cardiomyopathy due to amino-terminal heterozygous missense lamin A/C mutations. Subramanyam L; Simha V; Garg A Clin Genet; 2010 Jul; 78(1):66-73. PubMed ID: 20041886 [TBL] [Abstract][Full Text] [Related]
14. LMNA-linked lipodystrophies: from altered fat distribution to cellular alterations. Bidault G; Vatier C; Capeau J; Vigouroux C; Béréziat V Biochem Soc Trans; 2011 Dec; 39(6):1752-7. PubMed ID: 22103520 [TBL] [Abstract][Full Text] [Related]
15. Familial partial lipodystrophy: a monogenic form of the insulin resistance syndrome. Hegele RA Mol Genet Metab; 2000 Dec; 71(4):539-44. PubMed ID: 11136544 [TBL] [Abstract][Full Text] [Related]
16. Lessons from human mutations in PPARgamma. Hegele RA Int J Obes (Lond); 2005 Mar; 29 Suppl 1():S31-5. PubMed ID: 15711581 [TBL] [Abstract][Full Text] [Related]
17. New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome. Decaudain A; Vantyghem MC; Guerci B; Hécart AC; Auclair M; Reznik Y; Narbonne H; Ducluzeau PH; Donadille B; Lebbé C; Béréziat V; Capeau J; Lascols O; Vigouroux C J Clin Endocrinol Metab; 2007 Dec; 92(12):4835-44. PubMed ID: 17711925 [TBL] [Abstract][Full Text] [Related]
18. Atypical generalized lipoatrophy and severe insulin resistance due to a heterozygous LMNA p.T10I mutation. Mory PB; Crispim F; Kasamatsu T; Gabbay MA; Dib SA; Moisés RS Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1252-6. PubMed ID: 19169477 [TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of nuclear lamin A mutations in Dunnigan-type familial partial lipodystrophy. Hegele RA; Cao H; Anderson CM; Hramiak IM J Clin Endocrinol Metab; 2000 Sep; 85(9):3431-5. PubMed ID: 10999845 [TBL] [Abstract][Full Text] [Related]
20. [Lipodystrophic syndromes: congenital or acquired diseases of adipose tissue]. Capeau J; Vigouroux C; Magré J; Lascols O; Caron M; Bastard JP C R Biol; 2006 Aug; 329(8):639-52; discussion 653-5. PubMed ID: 16860281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]